Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.49 - $4.91 $130,030 - $256,405
-52,221 Reduced 83.21%
10,535 $40,000
Q4 2023

Feb 14, 2024

SELL
$1.87 - $2.71 $24,381 - $35,332
-13,038 Reduced 17.2%
62,756 $148,000
Q3 2023

Nov 14, 2023

SELL
$2.62 - $3.91 $44,492 - $66,399
-16,982 Reduced 18.3%
75,794 $209,000
Q2 2023

Aug 14, 2023

SELL
$2.62 - $5.28 $49 - $100
-19 Reduced 0.02%
92,776 $292,000
Q1 2023

May 15, 2023

BUY
$4.9 - $9.49 $57,932 - $112,200
11,823 Added 14.6%
92,795 $483,000
Q4 2022

Feb 14, 2023

BUY
$5.91 - $14.28 $329,908 - $797,138
55,822 Added 221.96%
80,972 $600,000
Q3 2022

Nov 14, 2022

BUY
$7.64 - $14.97 $42,440 - $83,158
5,555 Added 28.35%
25,150 $315,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $11.37 $138,340 - $222,795
19,595 New
19,595 $150,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $129M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.